New research was published this week analyzing how AI can be used to better manage medications for senior patients who use multiple medications simultaneously. It analyzed FeelBetter’s AI platform, which pinpoints patients at high risk of deterioration and preventable hospitalization due to suboptimal medication management. The post AI Can Help Better Manage Polypharmacy Patients, Study…
A new KFF analysis examines a range of measures that may make it harder for states to respond to possible federal Medicaid cuts and finds that six states (Kentucky, Mississippi, Missouri, New Mexico, South Carolina, and West Virginia) rank in the top five for multiple risk categories. Across four broad categories of measures that could…
Other earnings-season takeaways related to insurance exchanges: Hospital companies are sticking to their loss estimates and Pediatrix executives had a non-event take.
SIKESTON, Mo. — In the summer of 2021, Sikeston residents organized the biggest Juneteenth party in the city’s history. Sikeston police officers came too, both to provide security for the event and to try to build bridges with the community. But after decades of mistrust, some residents questioned their motives. In the series finale of…
One platform predicts clinical demand and automates healthcare logistics, while another startup deploys hospital-wide AI solutions by embedding engineering teams on-site
Himanshu Shah, an activist investor and large shareholder of Novavax, whose stock has plummeted over the years, believes the company should cut costs more aggressively, reduce the size of its board, and do more to prop up its financial performance. But are the criticisms valid? The post Is Shah Capital’s Criticism of Novavax Fair? A…
Israeli cancer diagnostics startup SpoititEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients’ breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year. The post Meet the Startup Using…
Three medical school leaders discuss the threats of de-skilling and never skilling vs. the promise of upskilling
Neurocrine Biosciences’ Crenessity is now FDA approved for treating classic congenital adrenal hyperplasia (CAH), a rare and potentially fatal endocrine disorder. The approval comes with a priority review voucher, which Neurocrine could sell for around $150 million. The post Neurocrine Lands FDA Nod for First New Treatment in Decades for Rare Endocrine Disorder appeared first…
With the incoming Trump administration and Republican-led Congress looking to ways to reduce federal spending, this Poll finds that the Medicare and Medicaid programs remain broadly popular, and more people favor more spending on those programs than less spending. Among potential actions on health, the public sees price transparency and limiting chemicals in food as…